---
title: "NanFang Precision: There have been no significant changes in recent operating conditions and the internal and external operating environment"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236369002.md"
description: "NanFang Precision announced on April 17 that the cumulative deviation of the closing price increase of its A-shares reached 20.00% over three consecutive trading days from April 15 to 17, which constitutes an abnormal fluctuation. After verification, the company confirmed that there have been no significant changes in its recent operating conditions and internal and external environment. Apart from the refinancing matter that has been accepted by the Shenzhen Stock Exchange, there are no other significant matters that need to be disclosed"
datetime: "2025-04-17T08:31:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236369002.md)
  - [en](https://longbridge.com/en/news/236369002.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236369002.md)
generator: "portal-rs"
---

# NanFang Precision: There have been no significant changes in recent operating conditions and the internal and external operating environment

On April 17, NanFang Precision announced that the trading price of its A-shares had a cumulative closing price deviation of 20.00% over three consecutive trading days on April 15, April 16, and April 17, which falls under the category of abnormal stock trading fluctuations according to the relevant regulations of the Shenzhen Stock Exchange. After verification, there have been no significant changes in the company's operating conditions or the internal and external operating environment recently. Currently, apart from the refinancing matter that has been accepted by the Shenzhen Stock Exchange, the company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage

### Related Stocks

- [002553.CN](https://longbridge.com/en/quote/002553.CN.md)

## Related News & Research

- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [14:41 ETNine Corboy & Demetrio Attorneys selected to 2027 The Best Lawyers in America®](https://longbridge.com/en/news/296644470.md)
- [Cell C publishes pro forma financials after Comm Equipment Company merger](https://longbridge.com/en/news/296585930.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**